全文获取类型
收费全文 | 294411篇 |
免费 | 20290篇 |
国内免费 | 1130篇 |
专业分类
耳鼻咽喉 | 3059篇 |
儿科学 | 7560篇 |
妇产科学 | 5502篇 |
基础医学 | 37308篇 |
口腔科学 | 5372篇 |
临床医学 | 30777篇 |
内科学 | 60504篇 |
皮肤病学 | 4105篇 |
神经病学 | 29396篇 |
特种医学 | 12447篇 |
外国民族医学 | 13篇 |
外科学 | 46425篇 |
综合类 | 3399篇 |
现状与发展 | 1篇 |
一般理论 | 241篇 |
预防医学 | 22831篇 |
眼科学 | 6888篇 |
药学 | 19866篇 |
2篇 | |
中国医学 | 388篇 |
肿瘤学 | 19747篇 |
出版年
2023年 | 1506篇 |
2022年 | 2236篇 |
2021年 | 6426篇 |
2020年 | 3675篇 |
2019年 | 6118篇 |
2018年 | 7317篇 |
2017年 | 5377篇 |
2016年 | 5904篇 |
2015年 | 6998篇 |
2014年 | 10138篇 |
2013年 | 13757篇 |
2012年 | 21061篇 |
2011年 | 21881篇 |
2010年 | 12233篇 |
2009年 | 11194篇 |
2008年 | 19326篇 |
2007年 | 20345篇 |
2006年 | 19815篇 |
2005年 | 19562篇 |
2004年 | 18391篇 |
2003年 | 16939篇 |
2002年 | 16204篇 |
2001年 | 3018篇 |
2000年 | 2587篇 |
1999年 | 3094篇 |
1998年 | 3489篇 |
1997年 | 2766篇 |
1996年 | 2496篇 |
1995年 | 2348篇 |
1994年 | 2009篇 |
1993年 | 1957篇 |
1992年 | 1713篇 |
1991年 | 1604篇 |
1990年 | 1551篇 |
1989年 | 1376篇 |
1988年 | 1284篇 |
1987年 | 1136篇 |
1986年 | 1159篇 |
1985年 | 1254篇 |
1984年 | 1389篇 |
1983年 | 1188篇 |
1982年 | 1368篇 |
1981年 | 1285篇 |
1980年 | 1096篇 |
1979年 | 790篇 |
1978年 | 814篇 |
1977年 | 676篇 |
1976年 | 637篇 |
1975年 | 546篇 |
1974年 | 573篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
2.
3.
4.
5.
6.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
7.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
8.
9.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献
10.